Related references
Note: Only part of the references are listed.Psoriasis: from Pathogenesis to Targeted Therapies
Curdin Conrad et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation
Miao Xu et al.
IMMUNITY (2018)
Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches
Pooja Todke et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis
Lea Shallev et al.
RNA (2018)
Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation
Hui Li et al.
NATURE COMMUNICATIONS (2018)
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis
Curdin Conrad et al.
NATURE COMMUNICATIONS (2018)
Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors
Toshiya Takahashi et al.
SCIENTIFIC REPORTS (2018)
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
Cristina Albanesi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Type I Interferons in Autoimmune Disease
Mary K. Crow et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
Targeting IL-23 in psoriasis: current perspectives
Christina Fotiadou et al.
PSORIASIS-TARGETS AND THERAPY (2018)
Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation
Reiko Matsumoto et al.
JCI INSIGHT (2018)
Relative versus absolute risk of comorbidities in patients with psoriasis
Mohammed D. Saleem et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients
M. Masson Regnault et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Drug-induced psoriasis: clinical perspectives
Deepak M. W. Balak et al.
PSORIASIS-TARGETS AND THERAPY (2017)
Crystallinity of Double-Stranded RNA-Antimicrobial Peptide Complexes Modulates Toll-Like Receptor 3-Mediated Inflammation
Ernest Y. Lee et al.
ACS NANO (2017)
Rebound pustular psoriasis after brodalumab discontinuation
A. Khemis et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury
Ling-juan Zhang et al.
IMMUNITY (2016)
Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation
Jun Gui et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Secukinumab withdrawal leads to loss of treatment responses in a majority of subjects with plaque psoriasis with retreatment resulting in rapid regain of responses: A pooled analysis of two phase 3 trials
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE
Thomas Doerner et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Comorbidities of Psoriasis - Exploring the Links by Network Approach
Sudharsana Sundarrajan et al.
PLOS ONE (2016)
dsRNA Released by Tissue Damage Activates TLR3 to Drive Skin Regeneration
Amanda M. Nelson et al.
CELL STEM CELL (2015)
An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
Lynda Grine et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility
Xianyong Yin et al.
NATURE COMMUNICATIONS (2015)
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region
D. L. Armstrong et al.
GENES AND IMMUNITY (2014)
Type I interferons in Sjogren's syndrome
Yihong Yao et al.
AUTOIMMUNITY REVIEWS (2013)
Microarray Analyses Demonstrate the Involvement of Type I Interferons in Psoriasiform Pathology Development in D6-deficient Mice
Helen M. Baldwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
Andrew Johnston et al.
JOURNAL OF IMMUNOLOGY (2013)
The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
Michelle A. Lowes et al.
TRENDS IN IMMUNOLOGY (2013)
The role of type 1 interferon in systemic sclerosis
Minghua Wu et al.
FRONTIERS IN IMMUNOLOGY (2013)
Ctip2 is a dynamic regulator of epidermal proliferation and differentiation by integrating EGFR and Notch signaling
Ling-juan Zhang et al.
JOURNAL OF CELL SCIENCE (2012)
IFN-α Enhances IL-22 Receptor Expression in Keratinocytes: A Possible Role in the Development of Psoriasis
Mikiko Tohyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Psoriasis during natalizumab treatment for multiple sclerosis
Jorge Millan-Pascual et al.
JOURNAL OF NEUROLOGY (2012)
Ultraviolet radiation damages self noncoding RNA and is detected by TLR3
Jamie J. Bernard et al.
NATURE MEDICINE (2012)
Selective Ablation of Ctip2/Bcl11b in Epidermal Keratinocytes Triggers Atopic Dermatitis-Like Skin Inflammatory Responses in Adult Mice
Zhixing Wang et al.
PLOS ONE (2012)
Epithelial antimicrobial defence of the skin and intestine
Richard L. Gallo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis
Marie-Jose Bijlmakers et al.
HUMAN MOLECULAR GENETICS (2011)
Type I interferon pathway in adult and juvenile dermatomyositis
Emily C. Baechler et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
Josh Gregorio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Type I interferon: friend or foe?
Giorgio Trinchieri
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Psoriasis during interferon beta treatment for multiple sclerosis
Loredana La Mantia et al.
NEUROLOGICAL SCIENCES (2010)
Keratinocyte but Not Endothelial Cell-Specific Overexpression of Tie2 Leads to the Development of Psoriasis
Julie A. Wolfram et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Dipyaman Ganguly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Antonella Di Cesare et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury
Yuping Lai et al.
NATURE MEDICINE (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
CD300a/c regulate type I interferon and TNF-α secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands
Xinsheng Ju et al.
BLOOD (2008)
From conventional to cutting edge: the new era of biologics in treatment of psoriasis
Julia Tzu et al.
DERMATOLOGIC THERAPY (2008)
Type I Interferon: Potential Therapeutic Target for Psoriasis?
Yihong Yao et al.
PLOS ONE (2008)
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Roberto Lande et al.
NATURE (2007)
Psoriasis 1 - Pathogenesis and clinical features of psoriasis
Christopher E. M. Griffiths et al.
LANCET (2007)
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Roberto Baccala et al.
NATURE MEDICINE (2007)
Systemic lupus erythematosus: all roads lead to type I interferons
Virginia Pascual et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Type I interferon in systemic lupus erythematosus and other autoimmune diseases
Jacques Banchereau et al.
IMMUNITY (2006)
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
R Zenz et al.
NATURE (2005)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
FO Nestle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cross-regulation of TNF and IFN-α in autoimmune diseases
AK Palucka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
S Sano et al.
NATURE MEDICINE (2005)
In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered
L Van der Fits et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Endogenous antimicrobial peptides and skin infections in atopic dermatitis
PY Ong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2
M Pasparakis et al.
NATURE (2002)
CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling
S Hida et al.
IMMUNITY (2000)
Share Paper
